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Abstract
The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly 
increased accumulation of human genotypic, phenotypic and clinical data, and improved our 
understanding of the spectrum of clinical manifestations. As a result, the WHO disease 
classification of EVD underwent major revision.
Former filovirus disease names
Filoviruses, the members of the family Filoviridae, are currently classified into one proposed 
and five established genera (Supplementary Table 1). Of the twelve described filoviruses, six 
have been identified as aetiological agents of naturally occurring human disease outbreaks.
The International Classification of Diseases (ICD; Supplementary Box 1) is primarily a 
statistical tabulation. Consequently, frequently observed diseases with large patient cohorts 
are more likely to have their own disease names, codes and subcategories of disease 
manifestations than uncommonly occurring diseases because larger cohorts ensure statistical 
reliability of disease descriptions. Given the past low number of filovirus disease outbreaks 
and overall case numbers (34 disease outbreaks until 2 013, involving 2,872 cases and 1,968 
deaths), it is not surprising that the diseases caused by filoviruses were not captured by early 
ICD iterations. In ICD-9, the only code defining filovirus diseases was ‘078.89 Other 
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specified diseases due to viruses’. Consequently, various unofficial filovirus disease names 
have been used in the scientific literature (Supplementary Tables 2,3).
The currently used ICD-10 recognizes filovirus diseases specifically via entries ‘A98.4 
Ebola virus disease (EVD)’ and ‘A98.3 Marburg virus disease (MVD)’ since 1994. 
However, ICD-10 does not specify which filoviruses are considered to cause which of the 
two diseases, offer disease definitions or account for unusual disease manifestations (for 
example, subclinical or persistent infections).
A need for new filovirus disease names
In 2014, Ebola virus (EBOV) was identified as the aetiological agent of an EVD outbreak in 
Western Africa that, from 2013 to 2016, caused at least 28,652 human infections and 11,325 
deaths. This single outbreak involved almost ten times the combined number of patients 
from all previous filovirus disease outbreaks. Consequently, the clinical presentation of EVD 
could be refined using statistical measures, and subclinical EBOV infections leading to 
sexual transmission or disease relapse were substantiated through clinical observations. In 
addition, often-debilitating sequelae in EVD survivors were observed longitudinally for the 
first time using large cohorts. As clinical research data on EVD accumulated, the coverage 
of filovirus disease in ICD-10 was inadequate to cover complex clinical presentations of 
filovirus disease.
Discussion framework
Expert panel and method.
Responding to the WHO’s public call for input in the development of ICD-11, we assembled 
a large group of experts (the authors) who treated filovirus-infected patients or were heavily 
involved in organizing the treatment of patients to develop ICD-11’s entries on filovirus 
disease. Consensus was obtained by step-wise, simple-majority, semi-blind voting. The 
participants represented a wide spectrum of scientists and health workers of both sexes and 
from numerous countries, including African nations most affected by human filovirus 
infections.
Main issues.
ICD-10 recognizes two filoviruses diseases: EVD and MVD; however, four ebolaviruses 
(members of the genus Ebolavirus) cause disease, with EBOV only being one of them, and 
two marburgviruses (members of the genus Marburgvirus) cause disease, with Marburg 
virus (MARV) being one of them. The terms ‘Ebola virus disease’ and ‘Marburg virus 
disease’ are therefore ambiguous: either ICD-10 does not capture diseases caused by 
ebolaviruses and marburgviruses other than EBOV and MARV or EVD and MVD are cover 
terms for diseases caused by all ebolaviruses and marburgviruses (MARV and Ravn virus 
(RAVV)), requiring authors to specify which ebolavirus or marburgvirus caused a particular 
EVD or MVD outbreak. These ambiguities cause major confusion in communication among 
researchers and copy editors who are not necessarily familiar with the differences between 
‘Ebola virus’ and ‘ebolavirus’ or ‘Ebola virus disease due to Ebola virus infection’ versus 
‘Ebola virus disease due to Bundibugyo virus infection’1. Consequently, the expert panel 
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debated whether the EVD and MVD entries in ICD-10 should be merged into a single entry, 
whether the two terms should be split into several entries based on aetiological agents or 
whether a hierarchical scheme should be adopted to cover both possibilities.
Official virus taxonomy may change annually through decisions made by the International 
Committee on Taxonomy of Viruses (ICTV), but ICD updates and revisions are released at 
much longer intervals. Hence, the ICD cannot keep pace with taxonomic developments. 
Independence of ICD-11 filovirus disease names from virus taxonomy considerations was 
therefore thought to be imperative.
Results of expert panel discussions
A single umbrella term for the diseases caused by filoviruses is urgently needed, as 
differentiation between ICD-10’s EVD and MVD on clinical grounds alone is impossible. 
Following the publication of the ‘WHO Best Practices for the Naming of New Human 
Infectious Diseases’, this parent disease name should not contain any geographical 
locations; people’s names; species or class of animal or food; cultural, population, industry 
or occupational references; or components that incite undue fear2,3. Furthermore, the panel 
almost unanimously discouraged the use of ‘haemorrhagic fever’ for any filovirus-associated 
disease name because ‘haemorrhagic fever’ is not unambiguously defined, and the majority 
of filovirus-infected individuals do not develop overt haemorrhage. Consequently, health-
care workers could misdiagnose filovirus diseases, or potentially infected individuals may 
not seek admittance to a treatment unit based on the absence of haemorrhage. After thorough 
consideration, ‘Filovirus disease (FVD)’ was chosen as the ICD-11 parent disease term. 
Because filoviruses comprise a distinct and monophyletic group of viruses, the expert panel 
felt that the prefix ‘filo-’ was unlikely to disappear in the near future if taxonomic changes to 
the virus family would be required. Additional subcategories should be established to codify 
diseases caused by filovirus that have not yet been associated with filovirus disease or yet-
to-be-discovered novel filoviruses, diseases very likely caused by filoviruses without final 
agent confir mation, and filovirus diseases with ‘unusual’ clinical presentations.
The panel advocated for two subcategories to the filovirus parent entry for ebolavirus and 
marburgvirus diseases and recommended, if necessary, further subcategorization. The 
classical distinction of ICD-10’s EVD and MVD was felt to be important for traditional and 
familiarity reasons. Furthermore, molecular evidence is accumulating that ebolaviruses and 
marburgviruses behave differently in vitro and in vivo, suggesting that differences in clinical 
presentation of infections with ebolaviruses or marburgviruses will become evident in the 
future. ‘Ebola disease (EBOD)’ and ‘Marburg disease (MARD)’ were chosen for the major 
FVD subcategories (Box 1): FVD due to ebolavirus and marburgvirus infections, 
respectively. The WHO naming guidelines were not applied in coining these terms because 
both ‘Ebola’ and ‘Marburg’ have been components of filovirus disease names since the 
1970s and 1960s, respectively. The absence of the word ‘virus’ in the two disease names 
makes them taxonomically independent and therefore stable.
The panel then reintroduced the ICD-10 names ‘Ebola virus disease (EVD)’ and ‘Marburg 
virus disease (MVD)’ as EBOD and MARD subcategories because of their familiarity to the 
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filovirus research community but restricted the use of EVD and MVD to diseases caused by 
agents belonging to only one species: EBOV (species Zaire ebolavirus), and MARV and 
RAVV (both species Marburg marburgvirus), respectively. Two additional EBOD 
subcategory disease terms were added to cover the remaining pathogenic filoviruses that 
have caused more than one registered human infection: Bundibugyo virus disease (BVD) 
and Sudan virus disease (SVD). Three additional subcategories for both EBOD and MARD 
were proposed: ‘Atypical Ebola/Marburg disease’ for EBOD or MARD patients with 
unusual clinical presentations; ‘Other specified Ebola/Marburg disease’ for EBOD or 
MARD patients infected with ebolaviruses or marburgviruses not covered by BDV, EVD 
and SVD or MVD (for example, disease due to Taï Forest virus infection); and ‘Ebola/
Marburg disease, virus unspecified’ for patients who are suspected to be infected with an 
ebolavirus or marburgvirus in absence of virus identification.
The expert panel did not establish a separate category for filovirus-induced sequelae in 
filovirus disease survivors (for example, ‘post-Ebola syndrome’) as ICD-11 allows 
combinatorial coding (for example, ‘Atypical Ebola disease’ plus ‘Arthritis’).
New official filovirus disease names
The panel submitted a proposal containing the proposed filovirus disease classification and 
nomenclature to the WHO’s ICD-11 Proposal Platform in April 2018. After peer review and 
appropriate revisions, the new filovirus disease classification and nomenclature (Box 1; 
Supplementary Table 4) were accepted in May 2018 and subsequently incorporated into the 
ICD-11 framework. The panel recommends that the new filovirus disease names and 
abbreviations be used immediately in forthcoming filovirus publications to ensure a 
seamless transition once ICD-11 is adopted by United Nations member states.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Box 1 |
New WHO-accepted filovirus disease classification
Main disease category: 1D60 Filovirus disease (FVD)
• First disease subcategory: 1D60.0 Ebola disease (EBOD)
– Second disease subcategories: 1D60.00 Bundibugyo virus disease 
(BVD)a; 1D60.01 Ebola virus disease (EVD)b; 1D60.02 Sudan virus 
disease (SVD)c; 1D60.03 Atypical Ebola disease; 1D60.0Y Other 
specified Ebola diseased; 1D60.0Z Ebola disease, virus unspecified
• First disease subcategory: 1D60.1 Marburg disease (MARD)
– Second disease subcategories: 1D60.10 Marburg virus disease 
(MVD)e; 1D60.11 Atypical Marburg disease; 1D60.1Y Other 
specified Marburg disease; 1D60.1Z Marburg disease, virus 
unspecified
• First disease subcategory: 1D60.Y Other specified filovirus disease
• First disease subcategory: 1D60.Z Filovirus disease, virus unspecified
ICD-11, The International Classification of Diseases Revision 11. aCaused by 
Bundibugyo virus (BDBV). bCaused by Ebola virus (EBOV). cCaused by Sudan virus 
(SUDV). dCaused by, for instance, Taï Forest virus (TAFV). eCaused by Marburg virus 
(MARV) or Ravn virus (RAVV).
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